A Phase 1 open-label, single ascending dose study of ABA-201 in participants with new onset type 1 diabetes (Stage 3)

Project: Research project

Project Details

Description

A Phase 1 open-label, single ascending dose study of ABA-201 in participants with new onset type 1 diabetes (Stage 3)
StatusActive
Effective start/end date10/22/2410/20/35

Funding

  • ABATA THERAPEUTICS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.